$ACET Cashflow Statement | Understand Stock

$ACET

$3.90 -$0.04 (1.02%) After hours

$ACET Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense
Noncash lease expense
Stock-based compensation expense
Loss on disposal of lease assets
Loss on disposal of property and equipment
Net amortization of premiums and accretion discounts on investments
Goodwill impairment
Amortization of deferred debt issuance costs
Impairment of in-process research and development
Gain on remeasurement of contingent consideration liability
Remeasurement of contingent consideration liability
Amortization of deferred transaction costs

Changes in operating assets and liabilities:
Accounts receivable - related party
Prepaid expenses and other current assets
Other non-current assets
Accounts payable
Contract liabilities—related party
Operating lease liability
Accrued and other current and non-current liabilities
Other non-current liabilities

Net cash used in operating activities
Cash flows from investing activities
Proceeds from sales of marketable debt securities
Proceeds from maturities of marketable debt securities
Purchases of short-term treasury securities
Maturities of short term treasury securities
Purchase of property and equipment
Net cash provided by (used in) investing activities

Cash flows from financing activities
Proceeds from issuance of common stock pursuant to at-the-market offering, net of issuance costs
Proceeds from issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs
Proceeds from exercise of stock options
Proceeds from Employee Stock Purchase Plan
Taxes withheld and paid related to net share settlement of equity awards
Deferred issuance costs
Principal payments on finance leases
Net cash provided by financing activities
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents at the beginning of the period
Cash, cash equivalents at the end of the period
Supplemental cash flow information
Cash received form tax refunds
Cash paid for income taxes
Supplemental disclosures of noncash investing and financing activities
Purchases of property and equipment included in accounts payable and accrued expenses
Operating right-of-use asset obtained in exchange for operating lease liability
Right-of-use asset acquired under finance leases
Offering costs in accounts payable and accrued expenses
Adjustment to Goodwill

Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets:
Cash and cash equivalents
Restricted cash

Comments